Concourse Financial Group Securities’s ENDRA Life Sciences NDRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5342 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6241 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6232 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6250 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6247 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6180 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6051 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5912 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5698 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5692 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5510 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5494 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5388 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5396 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5250 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5080 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4940 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4810 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4614 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4487 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4474 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4414 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4205 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4400 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4339 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4218 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3933 |
|